Literature DB >> 11064108

Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice.

H Okunuki1, R Teshima, J Sakushima, H Akiyama, Y Goda, M Toyoda, J I Sawada.   

Abstract

Mast-cell-deficient W/W(v) mice were sensitized by oral administration of 0.1 and 1.0 mg ovalbumin (OVA) by gavage every day for 9 weeks, and active systemic anaphylaxis (ASA) was induced by intraperitoneal injection of OVA. The production of OVA-specific IgE and IgG1 by oral immunization of the W/W(v) mice was high, and the production of IL-4 by splenocytes re-stimulated with OVA in vitro was increased. In contrast, production of OVA-specific IgG2a and IgG2b was low, and production of IFN-gamma by splenocytes after re-stimulation with OVA in vitro was rather decreased. These findings suggest that Th2-dominant helper T-cell activation had occurred. No increase in serum histamine level was observed following ASA induction. However, the plasma platelet-activating factor (PAF) levels of the mice sensitized with 0.1 and 1.0 mg OVA by gavage increased significantly. The increases in plasma PAF correlated well with the ASA-associated decreases in body temperature, suggesting that PAF plays an important role in ASA in W/W(v) mice. Taken together the above findings indicate that W/W(v) mice are a good model not only for studying induction of food allergy but also for examining the role of PAF in food-induced hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064108     DOI: 10.1016/s0165-2478(00)00264-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Characterization of intestinal dendritic cells in murine norovirus infection.

Authors:  Xiuxu Chen; Daniel Leach; Desiré A Hunter; Daniel Sanfelippo; Erika J Buell; Sarah J Zemple; Mitchell H Grayson
Journal:  Open Immunol J       Date:  2011

Review 2.  Mediators released during human anaphylaxis.

Authors:  Shelley F Stone; Simon G A Brown
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.